or Try an Advanced Search...

    Technical Analysis for DWTX - Dogwood Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 4.37 0.46% 0.02
    DWTX closed up 0.46 percent on Friday, November 1, 2024, on 62 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average.
    Earnings due: Nov 7
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical DWTX trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    50 DMA Resistance Bearish 0.46%
    1,2,3 Pullback Bullish Bullish Swing Setup 0.46%
    Inside Day Range Contraction 0.46%
    Wide Bands Range Expansion 0.46%
    Gapped Up Strength 0.46%
    50 DMA Resistance Bearish 5.05%
    Older End-of-Day Signals for DWTX ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 21 hours ago
    Possible Inside Day about 21 hours ago
    Rose Above 50 DMA about 24 hours ago
    Rose Above 10 DMA about 24 hours ago
    Down 1% about 24 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    DWTX Chart by TradingView
    Basic chart:

    Profile

    Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Disease Pain Antiviral Drug Rheumatology Fibromyalgia Antiviral Therapies

    Is DWTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 31 Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024
    Oct 30 Dogwood Therapeutics regains compliance with Nasdaq's minimum bid price rule
    Oct 30 Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
    Oct 14 DWTX: Virios Therapeutics Becomes Dogwood Therapeutics; Focus on Chemotherapy-Induced Neuropathic Pain…
    Oct 8 Virios Therapeutics Transforms into Dogwood Therapeutics
    Oct 7 Virios Therapeutics Enters Into Definitive Merger Agreement With Wex Pharmaceuticals
    Oct 7 Virios, and Wex Pharmaceuticals report business combination to form Dogwood Therapeutics
    Oct 7 Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
    Aug 13 VIRI: Enrollment Complete in Phase 2a Long COVID Trial; Results Expected in October 2024…
    Aug 9 Virios Therapeutics reports Q2 results
    See more DWTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 26.0
    52 Week Low 2.501
    Average Volume 109,407
    200-Day Moving Average 7.29
    50-Day Moving Average 4.43
    20-Day Moving Average 4.10
    10-Day Moving Average 4.41
    Average True Range 0.60
    RSI (14) 53.27
    ADX 37.21
    +DI 26.44
    -DI 14.62
    Chandelier Exit (Long, 3 ATRs) 3.48
    Chandelier Exit (Short, 3 ATRs) 4.31
    Upper Bollinger Bands 5.16
    Lower Bollinger Band 3.03
    Percent B (%b) 0.63
    BandWidth 51.96
    MACD Line 0.03
    MACD Signal Line -0.02
    MACD Histogram 0.0527
    Fundamentals Value
    Market Cap 84.16 Million
    Num Shares 19.3 Million
    EPS -0.16
    Price-to-Earnings (P/E) Ratio -27.31
    Price-to-Sales 0.00
    Price-to-Book 1.63
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.72
    Resistance 3 (R3) 4.72 4.62 4.66
    Resistance 2 (R2) 4.62 4.53 4.61 4.64
    Resistance 1 (R1) 4.49 4.47 4.56 4.49 4.62
    Pivot Point 4.39 4.39 4.42 4.38 4.39
    Support 1 (S1) 4.26 4.30 4.33 4.26 4.12
    Support 2 (S2) 4.16 4.24 4.15 4.10
    Support 3 (S3) 4.03 4.16 4.08
    Support 4 (S4) 4.03